WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Lung Cancer efficacy endpoints v5, -cough -shortness of breath -chest pain -fatigue -other specifying severity, Karnofsky with allowed values 0, 10, 20...100, Therapeutic Efficacy Endpoint is intersection of Therapeutic Intervention, Short axis for target lymph nodes measured in mm, Progression free survival (PFS) derived from Tumor Response, Lesion has type New lesion, Informational or proposed for removal concepts identified by grey color boxes, Tumor Response assesses Lesion, LD (axial plane) for target lesion measured in mm, Duration of response measured at Date of tumor progression, Time to progression of cancer symptoms includes Name of the PRO instrument, Objective Response Rate (ORR) measured at Date of initial response, Sum of longest diameters (SLD) has_component LD (axial plane) for target lesion, Non-target lesion have response options -Complete Response (CR) -Non-CR/non-PD -Not evaluated -Not all evaluated -Non-PD -PD -Unequivocal PD -Any, - CR - PR derived from Sponsor specified Response Criteria (e.g. RECIST), Concepts are denoted by solid round-edged rectangle, Anatomical region instantiated by -Lung -CNS (brain, leptomeninges) -Bone -Liver -Adrenal (L, R) -Mediastinum (anterior, middle, posterior) -Hilar (L, R) -Plural Fluid, LUNG CANCER EFFICACY ENDPOINTS include Time to progression of cancer symptoms, Lesion identified by Organ specific lesion ID, Objective Response Rate (ORR) measured at Date of tumor progression